NewSquare Capital LLC Has $64,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

NewSquare Capital LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 123 shares of the medical equipment provider’s stock after buying an additional 23 shares during the period. NewSquare Capital LLC’s holdings in Intuitive Surgical were worth $64,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Howard Capital Management Group LLC grew its position in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares in the last quarter. Impax Asset Management Group plc grew its position in shares of Intuitive Surgical by 43.9% during the 3rd quarter. Impax Asset Management Group plc now owns 5,167 shares of the medical equipment provider’s stock worth $2,538,000 after purchasing an additional 1,577 shares in the last quarter. Crestwood Advisors Group LLC grew its position in shares of Intuitive Surgical by 3.2% during the 3rd quarter. Crestwood Advisors Group LLC now owns 4,432 shares of the medical equipment provider’s stock worth $2,177,000 after purchasing an additional 139 shares in the last quarter. Avidian Wealth Enterprises LLC grew its position in shares of Intuitive Surgical by 7.0% during the 3rd quarter. Avidian Wealth Enterprises LLC now owns 656 shares of the medical equipment provider’s stock worth $322,000 after purchasing an additional 43 shares in the last quarter. Finally, Catalina Capital Group LLC grew its position in shares of Intuitive Surgical by 6.6% during the 3rd quarter. Catalina Capital Group LLC now owns 2,668 shares of the medical equipment provider’s stock worth $1,311,000 after purchasing an additional 166 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 12,598 shares of company stock worth $7,223,467 over the last three months. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

ISRG stock opened at $568.02 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The company has a fifty day moving average price of $571.70 and a 200-day moving average price of $530.90. The company has a market capitalization of $202.32 billion, a P/E ratio of 88.61, a PEG ratio of 5.85 and a beta of 1.43.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. Finally, Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.